CAS RN: 1809249-37-3

Remdesivir

Product Availability

Choose a grade to view its available package options.

8 package records7 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250112 100g Out of stock Inquiry
Batchno.20250327 1g In stock Shanghai, Wuhan, Chengdu Inquiry
Batchno.20250920 1mg In stock Shanghai Inquiry
Batchno.20250726 250mg In stock Shanghai, Tianjin, Chengdu Inquiry
Batchno.20250116 25g In stock Tianjin, Wuhan, Chengdu Inquiry
Batchno.20251024 25mg In stock Shanghai Inquiry
Batchno.20260409 5g In stock Tianjin, Wuhan, Chengdu Inquiry
Batchno.20250828 5mg In stock Shanghai Inquiry
  • Product code: starshine_CAS1809249-37-3
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1809249-37-3 / 2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate

Standard CAS: 1809249-37-3 Multi CAS: No

Basic Information

CAS
1809249-37-3
Multi CAS
No
Molecular Formula
C27H35N6O8P
Molecular Weight
602.600000
Exact Mass
602.225399
SMILES
CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@@H]1[C@H]([C@H]([C@](O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4
InChI
InChI=1S/C27H35N6O8P/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)/t17-,21+,23+,24+,27-,42-/m0/s1
InChIKey
RWWYLEGWBNMMLJ-YSOARWBDSA-N

Computed Properties

Structural Parameters

Heavy atom count
42
Aromatic heavy atom count
15
Fraction Csp3
0.48
Rotatable bonds
13
H-bond acceptors
13
H-bond donors
4
Molar refractivity
149.83
TPSA
203.55

LogP / Solubility

WLOGP
2.31
MLOGP
2.08
XLogP3
1.9
Consensus LogP
2.1
Log S (ESOL)
-4.44
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.17
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.06
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-4.75

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
7.5

Safety & Transport

Pictogram(s)
Irritant Health Hazard
Signal
Danger
GHS Hazard Statements
H302 (33.3%): Harmful if swallowed [Warning Acute toxicity, oral] H315 (33.3%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (33.3%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (33.3%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] H372 (33.3%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]
Precautionary Statement Codes
P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501

Get In Touch

Contact Us